https://www.baystatetimes.com/article/904993962-peo-model-enables-small-employers-to-access-enterprise-level-benefits-packages Bay State Times en PressRelease 2026-04-10T22:16:58+00:00 PEO Model Enables Small Employers to Access Enterprise-Level Benefits Packages https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24830583-peo-model-enterprise-level-be-2400x1260.png https://www.baystatetimes.com/article/905057092-alleron-expert-group-marks-six-years-of-100-client-retention-announces-expanded-cloud-services-portfolio Bay State Times en PressRelease 2026-04-11T03:26:49+00:00 Alleron Expert Group Marks Six Years of 100% Client Retention, Announces Expanded Cloud Services Portfolio https://ml.globenewswire.com/media/ZGU2ZmY4NzctZTQ5MS00NTk2LTg2MjItYWM2NGE0OTIzYmQ1LTUwMDE2MTA0Mi0yMDI2LTA0LTExLWVu/tiny/Alleron-Expert-Group.png https://www.baystatetimes.com/article/904990418-replimune-receives-complete-response-letter-from-the-fda-for-rp1-biologics-license-application-for-the-treatment-of-advanced-melanoma Bay State Times en PressRelease 2026-04-10T21:02:32+00:00 Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma https://ml.globenewswire.com/media/Y2ExYzg2MzEtNjQxMi00MmIyLTg5NjQtM2JhYTU0YjVkOTAwLTExMjIxMDEtMjAyNi0wNC0xMC1lbg==/tiny/Replimune-Inc-.png https://www.baystatetimes.com/article/904989976-spyre-therapeutics-to-host-conference-call-to-report-spy001-part-a-induction-topline-results-from-skyline-trial-in-moderate-to-severe-ulcerative Bay State Times en PressRelease 2026-04-10T20:05:00+00:00 Spyre Therapeutics to Host Conference Call to Report SPY001 Part A Induction Topline Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients on April 13, 2026 https://ml.globenewswire.com/media/bc26a912-b583-43c6-8423-55a4ba2bf4bd/small/spyre-logo-horizontal-full-color-rgb-583px-300ppi-jpg.jpg https://www.baystatetimes.com/article/904990021-korro-bio-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4 Bay State Times en PressRelease 2026-04-10T20:05:00+00:00 Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/d49fc3c4-5cf6-4b89-8434-2eadfff25c26/small/korro-logo-rgb-jpg.jpg https://www.baystatetimes.com/article/904919848-global-bispecific-antibodies-market-to-reach-22-3-billion-by-2030-as-immuno-oncology-innovation-and-r-d-investment-accelerate Bay State Times en PressRelease 2026-04-10T12:15:20+00:00 Global Bispecific Antibodies Market to Reach $22.3 Billion by 2030 as Immuno-Oncology Innovation and R&D Investment Accelerate https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png https://www.baystatetimes.com/article/903404445-woburn-aesthetician-offers-exclusive-new-glac-by-candela-skin-treatment-at-woman-owned-spa Bay State Times en PressRelease 2026-04-09T22:35:47+00:00 Woburn Aesthetician Offers Exclusive New Glacē™ by Candela Skin Treatment at Woman-Owned Spa https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24829907-luann-skin-studio-57-glace-devi-750x1000.png https://www.baystatetimes.com/article/904749875-apg-157-reduces-hpv-viral-load-and-activates-anti-tumor-immunity-in-head-neck-cancer-presentation-at-aacr-2026 Bay State Times en PressRelease 2026-04-09T18:30:00+00:00 APG-157 Reduces HPV Viral Load and Activates Anti-Tumor Immunity in Head & Neck Cancer: Presentation at AACR 2026 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/21354648-aveta-logo-2518x345.jpeg https://www.baystatetimes.com/article/904746901-autura-and-yassi-partner-to-modernize-towing-lien-processing-nationwide Bay State Times en PressRelease 2026-04-09T17:25:27+00:00 Autura and YASSI Partner to Modernize Towing Lien Processing Nationwide https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24829685-autura-yassi-partnership-1500x1000.jpeg https://www.baystatetimes.com/article/904785369-sobi-receives-health-canada-approval-for-empaveli-pegcetacoplan-for-the-treatment-of-c3g-and-primary-ic-mpgn Bay State Times en PressRelease 2026-04-09T20:21:28+00:00 Sobi Receives Health Canada Approval for EMPAVELI® (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN https://ml.globenewswire.com/media/571c0204-b76a-4bba-b586-03bedbc971b9/small/sobi-logo-png-0-png.png https://www.baystatetimes.com/article/904785492-sobi-re-oit-l-autorisation-par-sant-canada-pour-empavelimd-pegc-tacoplan-dans-le-traitement-de-la-gc3-et-de-la-gnmp-ci-primitive Bay State Times en PressRelease 2026-04-09T20:21:28+00:00 Sobi reçoit l’autorisation par Santé Canada pour EMPAVELIMD (pegcétacoplan) dans le traitement de la GC3 et de la GNMP-CI primitive. https://ml.globenewswire.com/media/571c0204-b76a-4bba-b586-03bedbc971b9/small/ https://www.baystatetimes.com/article/904782009-crane-nxt-announces-dates-for-first-quarter-2026-earnings-release-and-earnings-call Bay State Times en PressRelease 2026-04-09T20:05:00+00:00 Crane NXT Announces Dates for First Quarter 2026 Earnings Release and Earnings Call https://ml.globenewswire.com/media/46b6dbd4-e1a7-4354-a280-7b7f3345327e/small/cranenxtlogo-png.png https://www.baystatetimes.com/article/904782432-rapid7-to-report-first-quarter-2026-financial-results-on-may-5 Bay State Times en PressRelease 2026-04-09T20:05:00+00:00 Rapid7 to Report First Quarter 2026 Financial Results on May 5 https://ml.globenewswire.com/media/06ff63c6-b10c-4136-b7b8-ee70f03d0bfd/small/rapid7-logo.jpg https://www.baystatetimes.com/article/904762573-integrative-experiment-design-reveals-hidden-patterns-in-decades-old-social-science-research Bay State Times en PressRelease 2026-04-09T18:05:00+00:00 Integrative experiment design reveals hidden patterns in decades-old social science research https://ml.globenewswire.com/media/ZWQxZWQ4NmMtNTQ4YS00NzZmLWFhMDAtNWM2MmU1NzVjMGU4LTEyNzMzMTEtMjAyNi0wNC0wOS1lbg==/tiny/MIT-Sloan-School-of-Management.png https://www.baystatetimes.com/article/904762418-cynet-named-leader-and-outperformer-in-2026-gigaom-radar-for-extended-detection-and-response-xdr Bay State Times en PressRelease 2026-04-09T16:55:41+00:00 Cynet Named Leader and Outperformer in 2026 GigaOm Radar for Extended Detection and Response (XDR) https://ml.globenewswire.com/media/41b0669e-e65b-448b-9a2f-4140d51fa2cd/small/cynet-logo-2c-png.png https://www.baystatetimes.com/article/904744047-wyss-institute-technologies-enable-breakthrough-in-astronaut-health-research-aboard-nasa-s-artemis-ii-mission Bay State Times en PressRelease 2026-04-09T15:00:00+00:00 Wyss Institute Technologies Enable Breakthrough in Astronaut Health Research Aboard NASA’s Artemis II Mission https://ml.globenewswire.com/media/YTA0ZDRjNjAtNTAyZS00MDQ3LTlhY2MtOWRmZDhmNWQ4YzBhLTEyMjI2MTktMjAyNi0wNC0wOS1lbg==/tiny/Wyss-Institute-at-Harvard-Univ.png https://www.baystatetimes.com/article/904744140-aspen-aerogels-provides-update-on-incident-at-east-providence-facility Bay State Times en PressRelease 2026-04-09T15:00:00+00:00 Aspen Aerogels Provides Update on Incident at East Providence Facility https://ml.globenewswire.com/media/ZmEyZjg4MGEtZmU0MS00MmYyLTkzMDMtMmQ4ZjJiOGRlMzE5LTExODkyMzEtMjAyNi0wNC0wOS1lbg==/tiny/Aspen-Aerogels-Inc-.png